保留髂内动脉血流的术者改良装置在动脉瘤腔内修复术中的中期结果:单中心经验
单中心2011年3月至2021年5月连续15例择期植入术者改良髂分支装置(sm IBD)以保留髂内动脉前向血流,技术成功率100%,1年与5年髂内动脉桥接支架通畅率分别为100%与85.7%±13.2%,1例分支闭塞无症状,1例再干预,1例II型内漏密切随访。
要点
- sm IBD用于髂总动脉瘤合并挑战性解剖(伴或不伴腹主动脉瘤)患者,技术成功率100%。
- 术后1年髂内动脉桥接支架通畅率100%,5年85.7%±13.2%。
- 1例(6.7%)髂内动脉分支闭塞无症状,1例(6.7%)再干预,1例(6.7%)II型内漏密切随访。
核心结论
- 使用IBD维持盆腔血流是有效且可行的血管腔内技术,尤其适用于髂动脉解剖异常的患者。
- 该新技术的中期手术成功率与商用IBD相似,更适合某些解剖挑战的患者,可作为替代治疗。
研究设计与样本
- 单中心2011年3月至2021年5月连续择期植入IBD的病例数据。
- 共纳入15例患者(15例男性,平均年龄67.6±7.9岁),植入15枚sm IBD。
- 14例(93.3%)同期行EVAR,1例(6.7%)既往因双侧髂总动脉瘤行EVAR修复。
- sm IBD适用于髂总动脉瘤合并挑战性解剖、伴或不伴腹主动脉瘤的患者。
主要发现
- 平均髂总动脉直径36.6±12.5 mm。
- 技术成功15例(100%)。
- 中位手术时间189.7±78.6 min,中位透视时间45.3±15.9 min。
- 11例(73.3%)采用腋动脉入路;平均总住院时间5.6±2.8天;术后随访35.4个月(范围2-120)。
- 术后1年髂内动脉桥接支架通畅率估计为100%,术后5年为85.7%±13.2%;1例(6.7%)髂内动脉分支闭塞且无症状。
临床怎么用
- 作者认为,使用IBD维持盆腔血流是有效且可行的血管腔内技术,尤其适用于髂动脉解剖异常的患者。
- 作者认为,该新技术中期手术成功率与商用IBD相似,更适合某些解剖挑战的患者,可作为替代治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: During endovascular aneurysm repair (EVAR), commercial iliac branch devices (IBDs) have become an inescapable alternative for preserving antegrade internal iliac artery (IIA) blood flow. Due to the different morphological features of aneurysms, commercial IBDs may not be suitable for all patients. Reported experience with the implantation of the new surgeon-modified IBD (sm IBD) is limited. This investigation describes the indications, efficacy, and safety of the sm IBD. METHODS: Data from consecutive elective implantations of IBDs in patients between March 2011 and May 2021 in a single center were incorporated. The sm IBDs were indicated in patients with common iliac artery aneurysms (CIAAs) and with a challenging anatomy and in those patients with or without abdominal aortic aneurysm (AAA). RESULTS: Fifteen patients (15 male, mean age 67.6 ± 7.9 years) were included. Fifteen sm IBDs were implanted in 1 procedure (100%). Fourteen (93.3%) patients had simultaneous endovascular aneurysm repair (EVAR) and 1 (6.7%) patient previously had a bilateral CIAAs repair by EVAR. The mean common iliac artery (CIA) diameter was 36.6 ± 12.5 mm. Technical success was obtained in all patients (100%). The median operation time was 189.7 ± 78.6 min, with a median fluoroscopy time of 45.3 ± 15.9 min. Axillary artery access was used in 11 (73.3%) procedures. The mean total hospital stay was 5.6 ± 2.8 days, and the postoperative follow-up was 35.4 months (range 2-120). The estimated IIA bridge stent patency at 1 year after operation was 100% and 85.7% ± 13.2% 5 years postoperatively. One (6.7%) IIA branch was occluded, and this patient remained asymptomatic. One patient (6.7%) needed reintervention, and another (6.7%) patient had type II leakage, which is currently under close surveillance. CONCLUSIONS: Using an IBD to maintain the pelvic blood flow is an effective and feasible intravascular technique, especially for patients with an abnormal iliac artery anatomy. This novel technique has similar midterm procedural success rate compared to the use of commercial IBDs. Therefore, these devices are more suitable for patients with certain anatomic challenges and can be used as an alternative treatment.
引用
- Wang C, Zhou Y, Shao J, et al. Midterm Results of a Surgeon-Modified Device to Preserve the Flow of the Internal Iliac Artery During Endovascular Repair of Aneurysm: Single-Center Experiences. Ann Vasc Surg. 2022. PMID: 36503023. doi:10.1016/j.avsg.2022.11.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。